The advantages of UK Biobank's open‐access strategy for health research

• DOI: 10.1111/joim.12955
• Publication Date: 2019-07-08T14:20:06Z
• Authors: M. Conroy; J. Sellors; M. Effingham; T. J. Littlejohns; C. Boultwood; L. Gillions; C. L. M. Sudlow; R. Collins; N. E. Allen
• Keywords: Investment

Abstract Ready access to health research studies is becoming more important as researchers, and their funders, seek maximize the opportunities for scientific innovation improvements. Large‐scale population‐based prospective are particularly useful multidisciplinary into causes, treatment prevention of many different diseases. UK Biobank has been established an open‐access resource public research, with intention making data widely available possible in equitable transparent manner. Access Biobank's unique breadth phenotypic genetic attracted researchers worldwide from across academia industry. As a consequence, it enabled scientists perform world‐leading collaborative research. Moreover, open already deeply characterized cohort encouraged both private sector investment further enhancements make unparalleled exemplar development approaches other studies.